A study reveals significant retinal vessel changes in diabetic retinopathy, highlighting the need for early detection methods ...

The global Diabetic Retinopathy Market is estimated to be valued at USD 9,830 million in 2025 and is projected to reach USD ...

Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...

If you’ve been diagnosed with diabetes, one of the issues doctors want to keep on top of is your eye health and whether the ...

Perfuse Therapeutics, Inc., a biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases, today announced positive results from two Phase 2 clinical ...

Shifa Trust (AST) has expressed profound concern over the escalating threat of Diabetic Retinopathy, attributing the rise to ...

A clinical trial involving 24 patients with non-proliferative diabetic retinopathy reported promising results using a ...

Frizziero L, Midena G, Longhin E, et al. Early retinal changes by Oct angiography and multifocal electroretinography in diabetes. J Clin Med. 2020;9:1–14. Agra CLDM, Lira RPC, Pinheiro FG, Sá LHSE, ...

Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against ...

Diabetic patients with high myopia have a significantly lower choroidal vascularity index (CVI) than those with diabetic retinopathy (DR), according to research published in Frontiers in Cell and ...

Studies of the retinal microcirculation using human donor eyes and high-resolution clinical imaging: Insights gained to guide future research in diabetic retinopathy, Progress in Retinal and Eye ...

New research has found that the endothelial cell-specific A disintegrin and metalloproteinase domain-containing protein 10 ...